Michael SabadoJan 10, 20200 min readHelp 4 HD Annual Report 201988 views0 comments7 likes. Post not marked as liked7
UniQureuniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease ~ No Significant Safety Concerns Observed